228 related articles for article (PubMed ID: 27020541)
1. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.
Lob SH; Hoban DJ; Sahm DF; Badal RE
Int J Antimicrob Agents; 2016 Apr; 47(4):317-23. PubMed ID: 27020541
[TBL] [Abstract][Full Text] [Related]
2. Resistance Rates of Intra-Abdominal Isolates from Intensive Care Units and Non-Intensive Care Units in the United States: The Study for Monitoring Antimicrobial Resistance Trends 2010-2012.
Hackel MA; Badal RE; Bouchillon SK; Biedenbach DJ; Hoban DJ
Surg Infect (Larchmt); 2015 Jun; 16(3):298-304. PubMed ID: 25894976
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
[TBL] [Abstract][Full Text] [Related]
4. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
Morfin-Otero R; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Koksal I; Yilmaz G; Unal S; Zarakolu P; Korten V; Mulazimoglu L; Tabak F; Mete B; Oguz VA; Gulay Z; Alp E; Badal R; Lob S
J Antimicrob Chemother; 2017 May; 72(5):1364-1372. PubMed ID: 28122913
[TBL] [Abstract][Full Text] [Related]
6. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea.
Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS
Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Liu YM; Chen YS; Toh HS; Huang CC; Lee YL; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Xu Y; Ni Y; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S11-7. PubMed ID: 22749053
[TBL] [Abstract][Full Text] [Related]
8. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
Keen EF; Murray CK; Robinson BJ; Hospenthal DR; Co EM; Aldous WK
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):728-32. PubMed ID: 20500036
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
10. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
11. Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006.
Wadl M; Heckenbach K; Noll I; Ziesing S; Pfister W; Beer J; Schubert S; Eckmanns T
Infection; 2010 Feb; 38(1):47-51. PubMed ID: 20108161
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile.
Bahador A; Raoofian R; Taheri M; Pourakbari B; Hashemizadeh Z; Hashemi FB
Microb Drug Resist; 2014 Dec; 20(6):632-40. PubMed ID: 25029126
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.
Shrestha S; Tada T; Miyoshi-Akiyama T; Ohara H; Shimada K; Satou K; Teruya K; Nakano K; Shiroma A; Sherchand JB; Rijal BP; Hirano T; Kirikae T; Pokhrel BM
Int J Antimicrob Agents; 2015 Nov; 46(5):526-31. PubMed ID: 26362951
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children's Medical Center of Tehran: a 6-year prospective study.
Soroush S; Haghi-Ashtiani MT; Taheri-Kalani M; Emaneini M; Aligholi M; Sadeghifard N; Pakzad I; Abedini M; Yasemi M; Paiman H
Acta Med Iran; 2010; 48(3):178-84. PubMed ID: 21137655
[TBL] [Abstract][Full Text] [Related]
15. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
16. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability.
Duarte A; Ferreira S; Almeida S; Domingues FC
Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918
[TBL] [Abstract][Full Text] [Related]
17. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
